Should FDA Warning Letter Prompt Securities Suit? Government, PhRMA Disagree
This article was originally published in The Pink Sheet Daily
Executive Summary
Supreme Court is to decide when Merck investors had sufficient information to sue for securities fraud; FDA warning letter about Vioxx risks is at issue.